United States / State guide

Peptides in Louisiana: verify the state record before the offer.

A Louisiana-specific peptide guide connecting seller and pharmacy claims to the state's official license route while keeping prescription, compounding, and laboratory research categories separate.

US research listing snapshotCompare 7 current BPC-157 listingsExact-size public listings kept separate from clinics and pharmacies.
Market brief

What changes in Louisiana.

In Louisiana, a local address, shipment promise, clinic page, or pharmacy name is only a starting claim. Louisiana Board of Pharmacy provides the official board route for resident, nonresident, professional, and facility license records, while federal product and compounding records answer separate questions.

  • Louisiana Board of Pharmacy maintains the official board route for resident, nonresident, professional, and facility license records; use the live result rather than a badge, screenshot, or seller-supplied license number alone.
  • FDA's BeSafeRx directory directs consumers to state licensing records and advises against online pharmacies that cannot be found in the relevant state database.
  • Peptide Local applies one national research-price snapshot to Louisiana and does not present those catalog rows as local pharmacies, clinical access, product approval, or a statewide legal conclusion.
Verification route

Know which record answers which question.

Local checklist

Three checks before any comparison.

Use this checklist to verify the local product, seller, and supply records before comparing price or availability.

01

Resolve the state credential

Use board of pharmacy licensing and verification to match the legal name, license type, address, and current status behind a pharmacy, professional, or facility claim involving Louisiana.

02

Keep federal proof separate

A Louisiana credential does not approve every product, ingredient, presentation, compounding basis, prescription route, or delivery claim. Check the applicable FDA record independently.

03

Compare equivalent offers only

Keep prescription care, compounded preparations, telehealth services, and laboratory research listings in separate lanes. For market rows, compare the same nominal size, availability date, shipping basis, and evidence access.

Direct answers

What this guide can - and cannot - answer.

Each answer is tied to the local records below so you can see what is confirmed, what remains unknown, and where to recheck it. Open the primary sources ↓

01

Can every peptide offer be treated as legal to buy in Louisiana?

No blanket answer is supportable. Use board of pharmacy licensing and verification to match the legal name, license type, address, and current status behind a pharmacy, professional, or facility claim involving Louisiana. In Louisiana, begin with Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy; the product, seller, and supply route still need to resolve to the same current record.

02

Does this page name the best place to buy peptides in Louisiana?

No. In Louisiana, the 78 us listings / 20 boards shown here are national laboratory-research catalog observations ordered by availability and public list price at a matched nominal size. They do not rank local pharmacies, clinics, prescription access, medical suitability, safety, or quality.

03

Which official records should I check first in Louisiana?

For Louisiana, start with Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy, then open Locate a state-licensed online pharmacy from U.S. Food and Drug Administration. The records answer separate questions, so confirm each current entry instead of treating one match as proof of the seller, product, and route together.

Compound and state routes

Tracked peptide names in Louisiana.

Each answer preserves the compound’s research, clinical, or medicine identity and then points to the official Louisiana verification route. A shared name or state license is not a blanket product, seller, legal, or availability finding.

01FDA-reviewed unapproved peptide identity

KPV in Louisiana

KPV in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
02US research-market identity

BPC-157 in Louisiana

BPC-157 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
03US research-market identity

TB-500 in Louisiana

TB-500 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
04US research-market identity

GHK-Cu in Louisiana

GHK-Cu in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
05US research-market identity

Semax in Louisiana

Semax in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
06US research-market identity

Melanotan II in Louisiana

Melanotan II in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
07US research-market identity

MOTS-c in Louisiana

MOTS-c in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
08US research-market identity with a separate FDA-licensed medicine record

Tesamorelin in Louisiana

Tesamorelin in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
09US research-market identity with a failed oral obesity program and no FDA-approved drug

AOD-9604 in Louisiana

AOD-9604 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
10US research-market identity

Ipamorelin in Louisiana

Ipamorelin in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
11US research-market identity

Selank in Louisiana

Selank in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
12US research-market identity with a separate FDA-approved medicine record

PT-141 / Bremelanotide in Louisiana

PT-141 / Bremelanotide in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
13US research-market identity

CJC-1295 no DAC in Louisiana

CJC-1295 no DAC in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
14US research-market identity

CJC-1295 DAC in Louisiana

CJC-1295 DAC in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
15Investigational clinical program

Retatrutide in Louisiana

Retatrutide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
16China-approved medicine and active clinical program

Mazdutide in Louisiana

Mazdutide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
17China-approved medicine and active development program

Ecnoglutide in Louisiana

Ecnoglutide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
18Investigational clinical program

Enicepatide in Louisiana

Enicepatide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
19Investigational clinical program

Eloralintide in Louisiana

Eloralintide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
20Investigational clinical program

Cagrilintide in Louisiana

Cagrilintide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
21Investigational clinical program

Petrelintide in Louisiana

Petrelintide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
22Investigational clinical program

CagriSema in Louisiana

CagriSema in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
23Investigational clinical program

MariTide in Louisiana

MariTide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
24Investigational clinical program

Survodutide in Louisiana

Survodutide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
25Investigational clinical program

VK2735 in Louisiana

VK2735 in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
26Investigational clinical program

Pemvidutide in Louisiana

Pemvidutide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
27Investigational clinical program

Amycretin / Zenagamtide in Louisiana

Amycretin / Zenagamtide in Louisiana refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
28US FDA medicine reference

Tirzepatide in Louisiana

Tirzepatide in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
29FDA-approved US medicine with country-specific status elsewhere

Orforglipron / Foundayo in Louisiana

Orforglipron / Foundayo in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
30Product-specific approved medicine records in multiple jurisdictions

Semaglutide in Louisiana

Semaglutide in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
31FDA-flagged unapproved research-market peptide identity

DSIP / Emideltide in Louisiana

DSIP / Emideltide in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
32US research-market identity

IGF-1 LR3 in Louisiana

IGF-1 LR3 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
33US research-market identity

Kisspeptin-10 / KP-10 in Louisiana

Kisspeptin-10 / KP-10 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
34US research-market identity separated from SCENESSE

Melanotan I in Louisiana

Melanotan I in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
35US research-market non-peptide coenzyme identity

NAD+ in Louisiana

NAD+ in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
36US research-market identity with a withdrawn historical medicine record

Sermorelin in Louisiana

Sermorelin in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
37No FDA-approved US product; exact foreign prescription products exist

Thymosin Alpha-1 in Louisiana

Thymosin Alpha-1 in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
38FDA-approved US medicine with a withdrawn EU application

EGRIFTA WR in Louisiana

EGRIFTA WR in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
39Product-specific FDA and EU medicine records

Liraglutide in Louisiana

Liraglutide in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
40Product-specific FDA and EU medicine records

SCENESSE in Louisiana

SCENESSE in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
41Product-specific FDA-approved US medicine record

VYLEESI in Louisiana

VYLEESI in Louisiana begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordBoard of Pharmacy licensing and verificationLouisiana Board of Pharmacy
Research listing snapshot

US public prices, kept in their category.

These listings are for laboratory research materials. They are not local clinics, pharmacies, or approved products for human use.

7/7 rows shown
Commercial-link disclosure: we may earn a commission after a click. Placement does not change price rank. Seller testing claims are labeled, not treated as our own verification.
Current board5 of 7 in stockAvailable list range $40.00–$92.00

Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.

Compare two lowest in-stock rows
Custom comparisonChoose two rows for a landed-cost check.Select any two seller rows. The calculator carries over list price and nominal milligrams, then lets you add shipping and mandatory fees.
0 / 2 selected
Select 2 more rows
Latest source recheck7/7current price and availability signals confirmed

Checked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.

Open source-check ledger
BPC-157 supplier prices, price per milligram, public evidence access, shipping claims, and source links
Price rank / supplier10 mg pricePrice / mgPublic evidenceShipping claimOpen listing
01Pure Health PeptidesPrice and stock confirmed Jul 27In stock
$4.00Public lot COA libraryAccess: Public link · Seller claim · Jul 27, 2026Free shipping over $175; lower-order rate at checkout
02Purgo LabsCurrent public batch reportIn stock
$4.50Public batch reportsAccess: Public link · Seller claim · Jul 23, 2026Live UPS rate; free UPS 3 Day Select over $250
03Pepta LabsFree US shipping claimedIn stock
$5.28COA on requestAccess: On request · Seller claim · Jul 23, 2026Free US shipping claimed
04Prime PeptidesPublic report linkedIn stock
$6.00Report displayedAccess: Public link · Seller claim · Jul 23, 2026$9.95 US; free over $150
05Biotech PeptidesPublic size-specific documentsIn stock
$9.20COA, LC, and MS imagesAccess: Public link · Seller claim · Jul 23, 2026Free USPS Priority over $200; lower-order rate not stated
06AminoCore ResearchPrice confirmed; stock not statedStatus not stated
$5.50COA includedAccess: Included with order · Seller claim · Jul 23, 2026Free shipping claimed
07Core PeptidesPrice shown; stock label absentStatus not stated
$9.70COA tab shownAccess: Public link · Seller claim · Jul 23, 2026Free over $200; lower-order rate at checkout
01

Pure Health Peptides

Price and stock confirmed Jul 27 · In stock
$40.00
Per mg
$4.00
Evidence
Public lot COA libraryPublic link
Shipping
Free shipping over $175; lower-order rate at checkout
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record
02

Purgo Labs

Current public batch report · In stock
$44.99
Per mg
$4.50
Evidence
Public batch reportsPublic link
Shipping
Live UPS rate; free UPS 3 Day Select over $250
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record
03

Pepta Labs

Free US shipping claimed · In stock
$52.79
Per mg
$5.28
Evidence
COA on requestOn request
Shipping
Free US shipping claimed
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record
05

Biotech Peptides

Public size-specific documents · In stock
$92.00
Per mg
$9.20
Evidence
COA, LC, and MS imagesPublic link
Shipping
Free USPS Priority over $200; lower-order rate not stated
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record
07

Core Peptides

Price shown; stock label absent · Status not stated
$97.00
Per mg
$9.70
Evidence
COA tab shownPublic link
Shipping
Free over $200; lower-order rate at checkout
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record
Primary sources

Repeat the checks yourself.

Official sources are linked directly. Open them to confirm the current record; this page is a guide, not a substitute for the regulator.

Related guides